More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Cynata Extends FUJIFILM Licence Option in GvHD

Mar 20, 2019 at 11:12 PM EDT · Issued by Cynata Therapeutics Limited

Filed with ASX · Mar 20, 2019 at 11:12 PM EDT · 1 page · English

On 6ix: 6ix.com/news/cynata-extends-fujifilm-licence-option-in-gvhd

Cynata Therapeutics Limited on 6ix

Story so far

  • Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHDDec 18, 2018
  • Cynata Completes Clinical Study Report in GvHDDec 18, 2018
  • Cynata GvHD Trial Meets all Safety & Efficacy EndpointsAug 30, 2018

Earlier from Cynata Therapeutics

  • Cynata Receives Favourable Advice on Planned CLI TrialMar 11, 2019
  • December 2018 Quarterly ReportJan 29, 2019
  • CYP Receives Notice of Acceptance from Aust Patent OfficeJan 6, 2019
  • Cynata Completes Clinical Study Report for Phase 1 Trial of CYP-001 in GvHDDec 18, 2018
  • Cynata Completes Clinical Study Report in GvHDDec 17, 2018

Later from Cynata Therapeutics

  • March 2019 Quarterly ReportApr 26, 2019
  • Cynata Strengthens Board & Executive Management TeamMay 19, 2019
  • June 2019 Quarterly ReportJul 4, 2019
  • Cynata confirms receipt of indicative non-binding proposalJul 18, 2019
  • Response to ASX Price and Volume QueryJul 19, 2019
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer